Proto Labs Inc (PRLB)

Financial leverage ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total assets US$ in thousands 772,353 784,245 777,210 791,373 802,168 906,938 918,649 934,751 928,582 930,311 949,290 934,448 744,204 726,126 698,445 678,090 673,667 654,899 645,527 618,596
Total stockholders’ equity US$ in thousands 695,295 684,922 682,685 683,137 697,648 810,846 820,698 832,035 828,493 824,621 831,977 813,431 644,356 625,821 601,249 587,740 585,790 564,097 558,113 542,795
Financial leverage ratio 1.11 1.15 1.14 1.16 1.15 1.12 1.12 1.12 1.12 1.13 1.14 1.15 1.15 1.16 1.16 1.15 1.15 1.16 1.16 1.14

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $772,353K ÷ $695,295K
= 1.11

The financial leverage ratio of Proto Labs Inc has shown some fluctuations over the past 8 quarters, ranging from 1.11 to 1.16. This ratio indicates the level of debt financing used by the company relative to its equity. A higher financial leverage ratio suggests that the company relies more on debt to finance its operations, which can magnify returns but also increase financial risk.

Proto Labs Inc's financial leverage ratio has generally been around 1.12 to 1.15, indicating a moderate level of leverage. The slight variations in the ratio over the quarters could be due to changes in the company's capital structure, such as taking on more debt or issuing additional equity.

It is important for investors and stakeholders to monitor Proto Labs Inc's financial leverage ratio to assess the company's ability to meet its debt obligations and manage financial risk effectively. A stable and optimal leverage ratio is crucial for maintaining financial health and sustainable growth in the long term.


Peer comparison

Dec 31, 2023

Company name
Symbol
Financial leverage ratio
Proto Labs Inc
PRLB
1.11
Arcosa Inc
ACA
1.53
Valmont Industries Inc
VMI
2.57